Alumis director granted RSUs and stock options
Alumis Inc. director Srinivas Akkaraju reported new equity awards and updated fund holdings.
Rhea-AI Filing Summary
Alumis Inc. director Srinivas Akkaraju reported new equity awards and updated fund holdings. He received a grant of 3,553 shares of common stock in the form of restricted stock units, plus stock options covering 15,528 shares at an exercise price of $28.14 per share. Both the RSUs and options vest on the first anniversary of the grant date, and in any event are fully vested by the issuer's 2027 annual stockholder meeting, subject to his continuous service and with full vesting upon a qualifying change in control.
After these grants, he directly holds 3,553 shares and options on 15,528 shares, and is associated with indirect holdings of 1,853,488 shares through Samsara Opportunity Fund, L.P. and 4,491,731 shares through Samsara BioCapital, L.P. The fund positions are held by those partnerships, with Akkaraju’s beneficial interest limited to his pecuniary stake.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 19,081 shares
Grant/Award
4 txns
Insider
AKKARAJU SRINIVAS
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 15,528 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 3,553 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 15,528 contracts (Direct);
Common Stock — 3,553 shares (Direct);
Common Stock — 4,491,731 shares (Indirect, By Samsara BioCapital, L.P.);
Common Stock — 1,853,488 shares (Indirect, By Samsara Opportunity Fund, L.P.)
Footnotes (4)
- F1. Represents shares of common stock issuable upon settlement of a restricted stock unit ("RSU") grant. The shares underlying this RSU vest on the first anniversary of the date of grant, provided that the shares will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2024 Equity Incentive Plan (the "Plan")) through such vesting date and will vest in full upon a Change in Control (as defined in the Plan), subject to the Reporting Person's Continuous Service (as defined in the Plan) through such date.
- F2. Shares are directly held by Samsara BioCapital LP. ("Samsara LP"). The Reporting Person is a managing member of Samsara BioCapital GP, LLC, the general partner of Samsara LP. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- F3. Shares are directly held by Samsara Opportunity Fund, L.P. ("Samsara Opportunity Fund"). Samsara Opportunity Fund GP, LLC is the general partner of Samsara Opportunity Fund and may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person has voting and investment power over the shares held by Samsara Opportunity Fund and, accordingly, may be deemed to beneficially own the shares held by Samsara Opportunity Fund. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein.
- F4. The shares underlying this option vest on the first anniversary of the date of grant, provided that the shares will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting, subject to the Reporting Person's Continuous Service (as defined in the Plan) through such vesting date and will vest in full upon a Change in Control (as defined in the Plan), subject to the Reporting Person's Continuous Service (as defined in the Plan) through such date.
Key Figures
RSU grant: 3,553 shares
Option grant size: 15,528 shares
Option exercise price: $28.14/share
+4 more
7 metrics
RSU grant
3,553 shares
Restricted stock units granted to director on 2026-06-30
Option grant size
15,528 shares
Stock options on common stock granted 2026-06-30
Option exercise price
$28.14/share
Exercise price for 15,528 stock options
Option expiration
June 29, 2036
Expiration date of stock option grant
Direct common shares after grant
3,553 shares
Director’s directly held Alumis common stock
Indirect holding via Samsara Opportunity Fund
1,853,488 shares
Common stock held by Samsara Opportunity Fund, L.P.
Indirect holding via Samsara BioCapital LP
4,491,731 shares
Common stock held by Samsara BioCapital, L.P.
Key Terms
restricted stock unit, RSU, 2024 Equity Incentive Plan, Change in Control, +1 more
5 terms
restricted stock unit financial
"Represents shares of common stock issuable upon settlement of a restricted stock unit ("RSU") grant."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
RSU financial
"Represents shares of common stock issuable upon settlement of a restricted stock unit ("RSU") grant."
Restricted stock units (RSUs) are a form of company shares given to employees as part of their compensation, usually with certain restrictions or conditions, such as remaining with the company for a set period. When these restrictions lift, employees receive actual shares that they can sell or hold. For investors, RSUs can impact a company's stock supply and reflect the company's commitment to attracting and retaining talent.
2024 Equity Incentive Plan financial
"subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2024 Equity Incentive Plan (the "Plan"))"
Change in Control financial
"will vest in full upon a Change in Control (as defined in the Plan)"
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
pecuniary interest financial
"The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."
FAQ
What did Alumis (ALMS) director Srinivas Akkaraju receive in this Form 4 filing?
He received 3,553 restricted stock units and options on 15,528 shares of Alumis common stock. These equity awards are compensation-related, with no cash paid, and reflect additional alignment with shareholder interests through stock-based incentives.
What is the exercise price and term of Srinivas Akkaraju’s Alumis stock options?
The stock options cover 15,528 shares at an exercise price of $28.14 per share. They expire on June 29, 2036, giving a long-dated right to buy Alumis common stock if the vesting conditions are satisfied.
How do the Alumis restricted stock units granted to Srinivas Akkaraju vest?
The 3,553 RSUs vest on the first anniversary of the grant date, and in any case are fully vested by the 2027 annual stockholder meeting, subject to continuous service and with full vesting upon a qualifying change in control under the company’s equity plan.
What indirect Alumis (ALMS) holdings are associated with Srinivas Akkaraju in the Form 4?
The filing lists 1,853,488 shares held by Samsara Opportunity Fund, L.P. and 4,491,731 shares held by Samsara BioCapital, L.P.. These shares are owned by the funds, with Akkaraju’s beneficial ownership limited to his pecuniary interest.
Does the Alumis Form 4 show any open-market buying or selling by Srinivas Akkaraju?
No open-market purchases or sales are reported. The Form 4 shows grant or award acquisitions of RSUs and options, plus updated indirect fund holdings, rather than discretionary market trades in Alumis common stock.
What happens to Srinivas Akkaraju’s Alumis RSUs and options if there is a change in control?
Both the RSUs and options vest in full upon a change in control, subject to his continuous service through that date. This treatment is defined under Alumis’ 2024 Equity Incentive Plan and its change in control provisions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
